Translational Studies Using the MALT1 Inhibitor ( S )-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer.
Mauro Di PilatoYun GaoYi SunAmina FuCarina GrassThomas SeeholzerRegina FeederleIrina MazoSamuel W KazerKevin LitchfieldUlrich H von AndrianThorsten R MempelRussell W JenkinsDaniel KrappmannPeter KellerPublished in: Journal of immunotherapy and precision oncology (2023)
)-mepazine succinate, in patients with advanced or metastatic treatment-refractory solid tumors.